Patterns and causes of suboptimal response to tenofovir-based therapy in individuals coinfected with HIV and hepatitis B virus.
about
Hepatitis B and human immunodeficiency virus co-infectionEmergence of Lamivudine-Resistant HBV during Antiretroviral Therapy Including Lamivudine for Patients Coinfected with HIV and HBV in ChinaHepatitis B virus coinfection in human immunodeficiency virus-infected patients: a review.Combination versus sequential monotherapy in chronic HBV infection: a mathematical approach.HBV genotypes and response to tenofovir disoproxil fumarate in HIV/HBV-coinfected persons.Proportion and factors associated with Hepatitis B viremia in antiretroviral treatment naïve and experienced HIV co-infected Ghanaian patients.Comparison of HBV-active HAART regimens in an HIV-HBV multinational cohort: outcomes through 144 weeks.Virological Response to Tenofovir Disoproxil Fumarate in HIV-Positive Patients with Lamivudine-Resistant Hepatitis B Virus Coinfection in an Area Hyperendemic for Hepatitis B Virus Infection.Hepatitis B Virus-HIV Coinfection: Forgotten but Not Gone.Slow CD4+ T-Cell Recovery in Human Immunodeficiency Virus/Hepatitis B Virus-Coinfected Patients Initiating Truvada-Based Combination Antiretroviral Therapy in Botswana.Factors associated with delayed hepatitis B viral suppression on tenofovir among patients coinfected with HBV-HIV in the CNICS cohortRisk of End-Stage Liver Disease in HIV-Viral Hepatitis Coinfected Persons in North America From the Early to Modern Antiretroviral Therapy Eras.Anti-hepatitis B activity of isoquinoline alkaloids of plant origin.HIV-hepatitis B virus co-infection: epidemiology, pathogenesis, and treatment.Five-year efficacy and safety of tenofovir-based salvage therapy for patients with chronic hepatitis B who previously failed LAM/ADV therapy.HBV-DNA levels predict overall mortality in HIV/HBV coinfected individuals.Outcomes in HIV/HBV-Coinfected Patients in the Tenofovir Era Are Greatly Affected by Immune Suppression.Therapeutic management and evolution of chronic hepatitis B: does HIV still have an impact? The EPIB 2012 study.Persistent viremia in human immunodeficiency virus/hepatitis B coinfected patients undergoing long-term tenofovir: virological and clinical implications.Clinical Outcomes during Treatment Interruptions in Human Immunodeficiency Virus-Hepatitis B Virus Co-infected Patients from Sub-Saharan Africa.End-Stage Liver Disease in HIV Infection: An Avoidable Burden?Adherence to Nucleos(t)ide Analogue Therapies for Chronic Hepatitis B Infection: A Systematic Review and Meta-Analysis
P2860
Q26822862-9FF4D7B7-C40E-44A3-97BA-A7CB42082402Q28547345-42C894D0-AF90-4064-AB98-A694335ECC66Q34405008-031497D4-839B-4660-BDEE-7A253D9D49DDQ35422530-51ABAF39-AD09-4EEF-9C3D-D6C5ED3A22C4Q35685474-ED5C314D-4C8C-44ED-80C9-4E12D3C21836Q35892317-8F4F4827-BE2B-448A-A2C8-F073A7B2A8B5Q35949791-9D5C4CD0-BFC4-4B9C-9260-9124BC264ADBQ36235577-2FC98EC5-DD6F-4F4D-A5EE-85205E8B738FQ37167046-F44F4C01-6B5E-4CBC-8ADF-DCCC8C4A6B0BQ37375386-E43493A1-1CF5-45A5-A769-2F3B29DDED8AQ37694907-A83C8DF8-F860-483C-95EE-3E9673DCBFE5Q38406226-1D8B404D-6FCD-4693-AB9E-AC58C936839EQ39047732-83D1043A-785D-4238-B73D-466B3F6D8643Q39425755-1CB0241F-5327-495A-86D0-47378DCF2CC1Q40431628-02D98B9D-5DDF-4727-BC26-DD2E0D533497Q40627202-4A769D35-D86F-427E-AFF0-1302B4B0CDFCQ41208197-3A7E0A49-F375-4DBF-9F55-A9015F970E7EQ41563379-57BED5B6-53CA-4101-95D0-1B813ACD570EQ42223115-563E7043-3A8C-4489-B5DA-75ED86722520Q45324809-BAB5FE20-43AE-48AC-A9CC-22FA6A4C0E8DQ50777220-7FE973B3-F8DB-4E22-94E8-1DCC3B18E830Q57069784-0917A3BC-48EC-4E4E-B7CF-28BC3066F588
P2860
Patterns and causes of suboptimal response to tenofovir-based therapy in individuals coinfected with HIV and hepatitis B virus.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Patterns and causes of subopti ...... ith HIV and hepatitis B virus.
@en
type
label
Patterns and causes of subopti ...... ith HIV and hepatitis B virus.
@en
prefLabel
Patterns and causes of subopti ...... ith HIV and hepatitis B virus.
@en
P2093
P2860
P50
P356
P1476
Patterns and causes of subopti ...... ith HIV and hepatitis B virus.
@en
P2093
Anchalee Avihingsanon
Chloe L Thio
Eric C Seaberg
Gail V Matthews
Gregory J Dore
Joe Sasadeusz
Melissa Saulynas
Robert Finlayson
Scott Bowden
Stephen Locarnini
P2860
P304
P356
10.1093/CID/CIT002
P407
P577
2013-01-11T00:00:00Z